News

Hyland’s tackles babies’ ‘unmet needs’

BY Michael Johnsen

LOS ANGELES — Hyland’s launched Hyland’s Baby Nighttime teething tablets, a nighttime version to join its best-selling infant oral pain reliever Hyland’s Baby teething tablets in the $40 million infant oral pain segment.

(For the full report, including charts, click here.)

The new product contains no benzocaine or melatonin. Hyland’s also introduced Hyland’s Baby Calming tTablets, citing an unmet need for a natural infant product for fussiness and occasional sleeplessness. According to Hyland’s, moms are 32% more likely to give their child a calming product if it is natural.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Arnica, baby care fuel natural growth

BY Michael Johnsen

The external analgesic ingredient arnica and baby care are two categories that are moving the needle across the homeopathic landscape. The leading arnica SKU Arnicare, from Boiron, generated sales of $13.4 million on growth of 43.9% for the 52 weeks ended July 13 across total U.S multi-outlets, according to IRI, well outpacing category growth of 7.5% for the same period.

(For the full report, including charts, click here.)

Arnica is a newer ingredient to the food, drug and mass arena, and it’s not just focused on pain, but also on bruising and swelling.

Similasan recently introduced its Similasan Arnica Active which is differentiated against other arnica products by its delivery system — a spray-on as opposed to a gel or roll-ons. “We’re one of the very first sprays in the mass market,” Dan Quail, Similasan VP, head of North America, told DSN. Because everybody gets the occasional bumps and bruises, a pain relieving ingredient that also reduces bruising is becoming well-known among consumers. “If you talk to people who know a little about homeopathy … the first [product] they’ve tried is arnica,” Quail said.

And Hyland’s continues to attract moms with both its Hyland’s Baby and Hyland’s 4 Kids lines. Baby is a key category for Hyland’s, especially as the company is able to make dosage recommendations for children as young as 6 months. That’s a three-and-a-half-year opportunity for the line of homeopathic products, as pediatric allopathic medicines are indicated for children ages 4 years and older.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Adherence key to outcomes

BY Michael Johnsen

Community pharmacists can dramatically help their patients stick to their prescription regimens, according to a new study led by researchers at the University of Pittsburgh School of Pharmacy. The findings, reported in August in Health Affairs, also suggest that greater adherence to medications can lead to a reduction in emergency room visits and hospital admissions, thereby lowering healthcare costs for a variety of chronic conditions, including diabetes and asthma.

(For the full Diabetes Report, including charts and additional coverage, click here.)

For the study — dubbed the Pennsylvania Project — staff from Pitt’s School of Pharmacy’s Program Evaluation and Research Unit (PERU) trained 283 community pharmacists to ask customers a few quick questions about medication adherence using established survey tools. They also were taught to have a brief dialog with patients whose screening scores indicated they were at risk of not taking their medications as prescribed by their doctors.

During 2011, 29,042 people had prescriptions filled at 107 Rite Aid pharmacies that implemented the screening and brief intervention approach (SBI), and 30,454 people who went to 111 “control” pharmacies that didn’t use SBI.

For the five classes of common medications the researchers reviewed, PDC rates of 80% or better increased in the SBI group during the intervention compared with the control group, ranging from 3.1% for beta blockers to treat high blood pressure to 4.8% for oral diabetes drugs. Healthcare costs dropped by $341 annually per person for SBI patients taking oral diabetes drugs and by $241 for SBI patients taking statins to lower cholesterol.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?